Shearman & Sterling represented HeartWare International, Inc. in connection with its first registered public offering in the United States consisting of $62.8 million of common stock. HeartWare is a medical device company focused on developing the world's smallest implantable blood pumps for the treatment of advanced heart failure. HeartWare’s shares are also listed on the Australian Stock Exchange. J.P. Morgan acted as the sole book-running manager of the offering, and Canaccord Adams, Lazard Capital Markets and Wedbush PacGrow Life Sciences acted as the co-managers of the offering.

The following Shearman & Sterling lawyers advised HeartWare in the transaction: partner Danielle Carbone (New York-Capital Markets); associates Ilir Mujalovic (New York-Capital Markets), Irene Shih (New York-Capital Markets), Sheila Lavu (New York-Capital Markets) and Hiroki Fuchiwaki (New York-Capital Markets); and legal assistant Robert Villa (New York-Capital Markets).